7Scheiman JM, Tillner A, Pohi T, et al. Reduction of non-stemidol antiintlammafory drug induced gastric injury and leucoryte endothelial adhlsion by octreotideet. Gut, 1997,40: 720-725.
10Nielsen JD, Holm-Nielsen A, Jespersen J, et al. The effect of low-does acetylsalicylic acid on bleeding after transurethral prostatectomya prospective, randomized, double-blind, placebo-cont rolled study. Stand J Urol Nephrol, 2000,34 : 194-198.
8Seheiman, Tillner A, Pohi T, et al. Reduction of non-steroidol anti-inflammafory drug induced gastric injury and leueoryte endothelial adhlsion by octreotide [J]. Gut, 1997, 40: 720.
9Poulter N.Global risk of cardiovascular disease[J].Heart,2003,89(Suppl):112-115
10Bengamin EJ,Smith SE,Jr Cooper RS,et al.Magnitude ot the prevention problem[J].J Am Coll Card,2002,40(4) :588.
2US Preventive Services Task Force.Aspirin for the prevention of cardiovascular disease:US Preventive Services Task Force recommendation statement[J].Ann Intern Med,2009,150(6):396-404.
3Antithrombotic Trialists' (ATT) Collaboration.Aspirin in the primary and secondary prevention of vascular disease:collaborative meta-analysis of individual participant data from randomised trials[J].Lancet,2009,373(9678):1849-1860.
4LaBresh KA,Ellrodt AG,Gliklich R,et al.Get with the guidelines for cardiovascular secondary prevention:pilot results[J].Arch Intern Med,2004,164(2):203-209.
5Mehta RH,Roe MT,Chen AY,et al.Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes:insights from the CRUSADE initiative[J].Arch Intern Med,2006,166(18):2027-2034.
6Newby LK,LaPointe NM,Chen AY,et al.Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease[J].Circulation,2006,113(2):203-212.
7Serebruany VL,Midei MG,Meilman H,et al.Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial[J].Int J Clin Pract,2006,60(7):863-866.
8Biondi-Zoccai GG,Lotrionte M,Agostoni P,et al.A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease[J].Eur Heart J,2006,27(22):2667-2674.
91999 World Health Organization-International Society of Hypertension Guidelines Subcommittee.Guidelines for the Management of Hypertension[J].J Hypertens,1999,17(2):151-183.
10Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(7):539-553.
